Compared to Estimates, Health Catalyst (HCAT) Q2 Earnings: A Look at Key Metrics

For the quarter ended June 2025, Health Catalyst (HCAT) reported revenue of $80.72 million, up 6.4% over the same period last year. EPS came in at $0.04, compared to $0.12 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $80.53 million, representing a surprise of +0.24%. The company delivered an EPS surprise of +33.33%, with the consensus EPS estimate being $0.03.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.Here is how Health Catalyst performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:Revenue- Professional services: $27.85 million compared to the $27.86 million average estimate based on four analysts. The reported number represents a change of -1.5% year over year.Revenue- Technology: $52.88 million versus $52.67 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a +11% change.Adjusted Gross Profit- Professional Services: $5.11 million versus $4.09 million estimated by four analysts on average.Adjusted Gross Profit- Technology: $34.85 million versus the four-analyst average estimate of $35.35 million.View all Key Company Metrics for Health Catalyst here>>>Shares of Health Catalyst have returned -5.2% over the past month versus the Zacks S&P 500 composite's +1.2% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.Beyond Nvidia: AI's Second Wave Is HereThe AI revolution has already minted millionaires. But the stocks everyone knows about aren't likely to keep delivering the biggest profits. Little-known AI firms tackling the world's biggest problems may be more lucrative in the coming months and years.See "2nd Wave" AI stocks now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Health Catalyst, Inc. (HCAT): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks